Tokyo, June 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058173) titled 'Impact of mavacamten on microvascular resistance in patents with obstructive hypertrophic cardiomyopathy' on June 13.
Study Type:
Observational
Primary Sponsor:
Institute - Kindai University
Condition:
Condition - Obstructive hyperthrophic cardiomyopathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the impact of mavacamten on coronary microvascular dysfunction in symptomtic patients with obstructive hypertrophic cardiomyopathy
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion...